Another clinical trial, using a voice-based conversational AI application to support type 2 diabetes patients, conducted by Nayak A. et al. (24), showed that insulin adherence rates were 32.7% higher in the AI-voice application compared to the standard care group (95% Confidence Interval from 8.0% to 57.4%, p = 0.01). The gene discussed is INS; the disease is type 2 diabetes mellitus.